Patent Assignment
Reel/Frame 047412/0284
Assignment of Assignor's Interest
Recorded: 2018-11-05
Pages: 11
Assignor
RFEMB HOLDINGS, LLC
Executed: 2018-06-19
Assignee
IMMUNSYS, INC.
2805 E. OAKLAND PARK BLVD., #451, FORT LAUDERDALE, NEW YORK, 33306
Covered Properties
(28)
System and Method For Creating Radio-Frequency Energy Electrical Membrane Breakdown For Tissue Ablation
Cancer Immunotherapy by Radiofrequency Electrical Membrane Breakdown (Rf-Emb)
Radio-Frequency Electrical Membrane Breakdown Using An Instant Charge Reversal Pulse Generator
Application:
61/867,048 →
Device and Process For Creating Radio-Frequency Energy Electrical Membrane Breakdown (RF-EMB) For Tissue Ablation
Application:
61/861,565 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of High Risk and Recurrent Prostate Cancer, Unresectable Pancreatic Cancer, Tumors of the Breast, Melanoma or Other Skin Malignancies, Sarcoma, Soft Tissue Tumors, Ductal Carcinoma, Neoplasia, and Intra and Extra Luminal Abnormal Tissue
Catheter Based Radio-Frequency Electrical Membrane Breakdown for the Treatment of Ductal Carcinoma, Neoplasia and Intra and Extra Luminal Abnormal Tissue from an Intraluminal Location
Application:
62/111,870 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Unresectable Pancreatic Cancer and Adjuvant Immunotherapy
Application:
62/110,646 →
Apparatus and Method for Radio-Frequency Electrical Membrane Breakdown Treatment of Tumors of the Breast with Immunologic Enhancement Through Enhanced Antigen Presentation
Application:
62/110,674 →
Apparatus and Method for Radio-Frequency Electrical Membrane Breakdown Treatment of Melanoma or Other Skin Malignancy with Immunologic Enhancement Through Enhanced Antigen Presentation
Application:
62/110,702 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Sarcoma and Soft Tissue Tumors Using Adjuvant Immunotherapy
Application:
62/110,733 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of High Risk and Recurrent Prostate Cancer Using a Minimally Invasive Office Based Procedure and Adjuvant Immunotherapy
Application:
62/109,965 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Cardiac Rhythm Disorders and for Renal Neuromodulation
Application:
15/549,194 →
Publication:
US 2018/0028264
Radio-Frequency Electrical Membrane Breakdown for Renal Neuromodulation
Application:
62/112,844 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Cardiac Rhythm Disorders
Application:
62/112,742 →
Radio-Frequency Electrical Membrane Breakdown for Reducing Restenosis
Application:
15/548,935 →
Publication:
US 2018/0021084
Radio-Frequency Electrical Membrane Breakdown for Reducing Restenosis
Application:
62/112,059 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Benign Prostatic Hyperplasia
Application:
15/548,877 →
Publication:
US 2018/0028267
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Benign Prostatic Hyperplasia
Application:
62/111,854 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Adipose Tissue and Removal of Unwanted Body Fat
Application:
15/548,908 →
Publication:
US 2018/0028260
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Adipose Tissue and Removal of Unwanted Body Fat
Application:
62/112,047 →
Immunologic Treatment of Cancer
Application:
62/279,579 →
Cancer Antigen Enhanced Presentation to Antigen Presenting Cells by Radiofrequency Electrical Membrane Breakdown (Rf-Emb) as an Adjuvant Mechanism for Immunotherapy
PCT:
PCT/US2014/068774 ↗
Radio-Frequency Electrical Membrane Breakdown for the Treatment of High Risk and Recurrent Prostate Cancer, Unresectable Pancreatic Cancer, Tumors of the Breast, Melanoma or Other Skin Malignancies, Sarcoma, Soft Tissue Tumors, Ductal Carcinoma, Neoplasia, and Intra and Extra Luminal Abnormal Tissue
PCT:
PCT/US2016/015944 ↗
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Cardiac Rhythm Disorders and for Renal Neuromodulation
PCT:
PCT/US2016/016955 ↗
Radio-Frequency Electrical Membrane Breakdown for Reducing Restenosis
PCT:
PCT/US2016/016501 ↗
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Benign Prostatic Hyperplasia
PCT:
PCT/US2016/016300 ↗
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Adipose Tissue and Removal of Unwanted Body Fat
PCT:
PCT/US2016/016352 ↗
Immunologic Treatment of Cancer
PCT:
PCT/US2017/013486 ↗
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 17, 2014
From: MIESSAU, JAMES A.; ONIK, GARY M.
To: RFEMB HOLDINGS, LLC
Reel/Frame 034187/0270 →
Assignment of Assignor's Interest
Jun 15, 2016
From: ONIK, GARY; MIESSAU, JIM; BOSTWICK, DAVID
To: RFEMB HOLDINGS, LLC
Reel/Frame 038920/0327 →
Assignment of Assignor's Interest
Nov 5, 2018
From: ONIK, GARY M.; MIESSAU, JAMES A.; BOSTWICK, DAVID G.
To: RFEMB HOLDINGS, LLC
Reel/Frame 047408/0754 →
Assignment of Assignor's Interest
Aug 2, 2019
From: ONIK, GARY; MIESSAU, JAMES A.
To: RFEMB HOLDINGS, LLC
Reel/Frame 049940/0007 →
Security Interest
Jun 14, 2023
From: IMMUNSYS, INC.
To: PHOENIX IMMUNO, LLC
Reel/Frame 063949/0493 →